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Figure 1. (a) Tumour DNA, showing C-+T transition at codon 248 (*). (b) 
Normal sequence at codon 248 (*). 
actinic keratoses and the response of many of these lesions to chemo-
therapeutic agents such as retinoids makes the further molecular 
delineation of these early events important. 
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ANNOUNCEMENT 
The 11 th Regional Conference of Dermatology (Asian-Australian) will be held May 21- 24, 
1994 in Singapore. The theme will be trends and recent developments in dermatology. The 
conference is being organized by The Dermatological Society of Singapore. 
Further information can be obtained from The Secretariat, 11th Regional Conference of 
Dermatology (Asian-Australasian), c/o Conference & Exhibition Management Services Pte 
Ltd, #09-43 World Trade Centre, Republic of Singapore 0409, Tel, 2788 666; Fax, 2784 077. 
Attention: Maggie Phang. 
